Leukocyte Filtration Removes Infectious Particulate Debris but Not Free Virus Derived from Experimentally Lysed HIV-infected Cells
- 1 May 1991
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 60 (4) , 214-218
- https://doi.org/10.1111/j.1423-0410.1991.tb00908.x
Abstract
We used in vitro model of storage-induced leukocyte degradation in blood to experimentally characterize the infectivity of the debris of lymphocytes harboring human immunodeficiency virus (HIV-1). The leukocyte filtration process removed both intact HIV-infected H9 cells and the particulate debris, but failed to remove the cell-free HIV released from lysed cells. These data suggest that the leukocyte filtration of donor blood soon after collection would optimally reduce the particulate infectious burden of blood for transfusions.Keywords
This publication has 12 references indexed in Scilit:
- Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood productsTransfusion, 1989
- Reduction of human immunodeficiency virus‐ infected cells from donor blood by leukocyte filtrationTransfusion, 1989
- PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALOVIRUS INFECTION IN INFANTS BY BLOOD FILTRATION TO REMOVE LEUCOCYTESThe Lancet, 1989
- Inactivation and Elimination of Viruses during the Fractionation of an Intravenous Immunoglobulin Preparation: Liquid Heat Treatment and Polyethylene Glycol FractionationVox Sanguinis, 1989
- PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUSThe Lancet, 1988
- VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 1988
- Mysteries of HIV: challenges for therapy and preventionNature, 1988
- Photodynamic therapy of viral contaminants with potential for blood banking applicationsTransfusion, 1988
- In Situ Hybridization and Immunocytochemistry for Improved Assessment of Human Immunodeficiency Virus CulturesAmerican Journal of Clinical Pathology, 1987
- Disinfection and Inactivation of the Human T Lymphotropic Virus Type III/Lymphadenopathy-Associated VirusThe Journal of Infectious Diseases, 1985